These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 10999815)

  • 1. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian inhibin subunit gene expression: regulation by gonadotropins and estradiol.
    Aloi JA; Dalkin AC; Schwartz NB; Yasin M; Mann B; Haisenleder DJ; Marshall JC
    Endocrinology; 1995 Mar; 136(3):1227-32. PubMed ID: 7867576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
    Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
    Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma inhibin levels following pulsatile gonadotrophin-releasing hormone therapy in a man with idiopathic hypogonadotrophic hypogonadism.
    Tsatsoulis A; Morris ID; Shalet SM; Robertson WR; de Kretser DM
    Horm Res; 1990; 33(1):18-21. PubMed ID: 2115857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of testicular Leydig cells reveals a role of endogenous inhibin in regulating follicle-stimulating hormone secretion in the adult male rat.
    Culler MD; Negro-Vilar A
    Mol Cell Endocrinol; 1990 Mar; 70(1):89-98. PubMed ID: 2160385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
    Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
    J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
    Schoot DC; Harlin J; Shoham Z; Mannaerts BM; Lahlou N; Bouchard P; Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jul; 9(7):1237-42. PubMed ID: 7962424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
    Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
    J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism.
    Smals AG; Hermus AR; Boers GH; Pieters GF; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1994 Mar; 78(3):602-8. PubMed ID: 8126131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and stage-specific effects of recombinant human follicle-stimulating hormone on the maintenance of spermatogenesis in gonadotropin-releasing hormone antagonist-treated rat.
    Hikim AP; Swerdloff RS
    Endocrinology; 1995 Jan; 136(1):253-61. PubMed ID: 7828538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.
    McLachlan RI; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Invest; 1988 Sep; 82(3):880-4. PubMed ID: 3138288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ; Dahl KD; Bremner WJ
    J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.